Mr. Ben-Noon is the Co-Founder and CEO of NeuroSense Therapeutics.
Prior to the establishment of NeuroSense, Alon founded MediCan Consulting, a successful consultancy firm, with clients from diversified biotech companies, including Mediwound, Chiasma, Teva, Sol-Gel, FutuRx, NeuroDerm and others. MediCan excelled at executing efficient, accurate, and innovative drug development programs for its clients.
Mr. Ben-Noon holds a MBA and BSc in Industrial Engineering, both from Ben-Gurion University.
